BENDURIC 5MG TABLETS
BENDROFLUMETHIAZIDE BP
What it does
Bendroflumethiazide is a medication that helps remove excess fluid from the body and is often used to manage high blood pressure.
Commonly used for: high blood pressure (hypertension), fluid retention (oedema)
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.
Source this medicineRegistration & product details
Source: Pharmacy and Poisons Board · fetched 2026-01-28 22:04:37 · updated 2026-05-08 07:34:53
About this medicine
Bendroflumethiazide is a medication that helps remove excess fluid from the body and is often used to manage high blood pressure.
What it treats
- high blood pressure (hypertension)
- fluid retention (oedema)
How it works
It works by helping the kidneys remove extra salt and water from the body, which lowers blood pressure and reduces swelling.
Who it's for
It is suitable for adults who need help controlling high blood pressure or managing fluid retention.
Drug class
Thiazide diuretics
Cautions
- • Be careful if you are taking medications that lower blood pressure.
- • Avoid medications that can lower potassium levels in the blood.
- • Use with caution if you are on medications that can cause low sodium levels.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: Bendroflumethiazide
BNF-referencedBendroflumethiazide is a thiazide diuretic used primarily for the management of hypertension and conditions related to fluid retention such as heart failure and nephrogenic diabetes insipidus.
Indications
- Hypertension
- Oedema in heart failure
- Nephrogenic diabetes insipidus
- Partial pituitary diabetes insipidus
- Management of chronic hypoglycaemia
Dosage
Children: For children aged 1 month to 1 year: 50–100 micrograms/kg daily; for children aged 1 to 11 years: Initially 50–400 micrograms/kg daily; for children aged 12–17 years: Initially 5–10 mg once daily.
Adults: Initially 2.5 mg once daily, adjusted according to response; maximum 10 mg per day.
Mechanism of action
Bendroflumethiazide works by inhibiting sodium reabsorption at the distal convoluted tubule in the kidneys, leading to increased excretion of sodium and water, which decreases blood volume and blood pressure.
Pharmacodynamics
As a thiazide diuretic, Bendroflumethiazide causes a dose-dependent diuresis and reduction in blood pressure. It also has effects on electrolyte balance, particularly reducing potassium levels and increasing calcium reabsorption.
Pharmacokinetics
Bendroflumethiazide is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1-3 hours after oral administration. It has a half-life of approximately 6-15 hours, and is primarily excreted in urine. Its effects can last for 24 hours or more.
Contra-indications
- Bilateral renovascular disease
- Severe or symptomatic aortic stenosis
- History of idiopathic or hereditary angioedema
Adverse effects
- Agranulocytosis
- Cholestasis
- Hypotension
- Angioedema
- Alopecia
- Blood disorders
Interactions
- Thiazide diuretics may interact with ACE inhibitors
- Increased risk of agranulocytosis in collagen vascular disease
Precautions
- Use with care in patients with hypertrophic cardiomyopathy
- Use with care in patients with a history of angioedema
Pregnancy
Use only if the benefits outweigh the risks; refer to specific guidelines.
Breast-feeding
The amount present in milk is too small to be harmful; large doses may suppress lactation.
Storage
Store below 25°C. Protect from light.
Formulations
- Bendroflumethiazide 2.5 mg tablets
- Oral suspension
- Oral solution
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: Bendroflumethiazide
PubChem CID 2315Molecular formula: C15H14F3N3O4S2
Mechanism of action
As a diuretic, bendroflumethiazide inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like bendroflumethiazide also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of bendroflumethiazide is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle. ...BENZOTHIADIAZIDES HAVE DIRECT EFFECT ON RENAL TUBULAR TRANSPORT OF SODIUM & CHLORIDE...INDEPENDENT OF ANY EFFECT ON CARBONIC ANHYDRASE. /THIAZIDE DIURETICS/ NATURE OF CHEM INTERACTION BETWEEN THIAZIDES & SPECIFIC RENAL RECEPTORS RESPONSIBLE FOR CHLORURETIC EFFECT IS NOT KNOWN; NO CRITICAL ENZYMATIC REACTIONS HAVE BEEN IDENTIFIED. /THIAZIDE DIURETICS/ ...MAY DECR EXCRETION OF URIC ACID IN MAN, THUS INCR ITS CONCN IN PLASMA. HYPERURICEMIC EFFECT RESULTS PRIMARILY FROM INHIBITION OF TUBULAR SECRETION OF URATE. ... UNLIKE MOST OTHER NATRIURETIC AGENTS...DECR RENAL EXCRETION OF CALCIUM RELATIVE TO THAT OF SODIUM... /ENHANCE/ EXCRETION OF MAGNESIUM... /THIAZIDE DIURETICS/ THIAZIDES INHIBIT REABSORPTION OF SODIUM &...CHLORIDE IN DISTAL SEGMENT. ... AS CLASS...HAVE IMPORTANT ACTION ON EXCRETION OF POTASSIUM THAT RESULTS FROM INCR SECRETION OF CATION BY DISTAL TUBULE. ... GLOMERULAR FILTRATION RATE MAY BE REDUCED BY THIAZIDES, PARTICULARLY WITH IV ADMIN FOR EXPTL PURPOSES. /THIAZIDE DIURETICS/ For more Mechanism of Action (Complete) data for BENDROFLUMETHIAZIDE (11 total), please visit the HSDB record page.
Pharmacodynamics
Bendroflumethiazide, a thiazide diuretic, removes excess water from the body by increasing how often you urinate (pass water) and also widens the blood vessels which helps to reduce blood pressure. It inhibits Na<sup>+</sup>/Cl<sup>-</sup> reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue.
Biological pathways
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.